BL-CV 625
BL-CV 625
BL-CV 625 Tablets – Broad Spectrum Antibiotic Protection with Probiotic Support
BL-CV 625 Tablets combine the power of Amoxycillin, Potassium Clavulanate, and Lactic Acid Bacillus to deliver effective treatment against a wide range of bacterial infections while supporting gut health. This advanced formulation is designed to provide enhanced antibacterial action, reduce antibiotic resistance, and help prevent antibiotic-associated diarrhea.
Composition
- Amoxycillin 500 mg
- Potassium Clavulanate 125 mg
- Lactic Acid Bacillus 60 million spores
Key Benefits
- Effective against a broad range of gram-positive and gram-negative bacteria
- Enhanced antibacterial protection with beta-lactamase inhibition
- Helps reduce the risk of antibiotic resistance and super infections
- Supports intestinal health with Lactic Acid Bacillus
- Helps prevent antibiotic-associated diarrhea
- Suitable for recurrent and uncomplicated infections
Indications
BL-CV 625 Tablets are commonly prescribed for:
- Chronic Bronchitis
- Bone & Joint Infections
- Urinary Tract Infections (UTI)
- Skin & Soft Tissue Infections
Advanced Triple Combination
Amoxycillin works by stopping bacterial growth, while Potassium Clavulanate enhances antibiotic effectiveness by inhibiting beta-lactamase enzymes. Lactic Acid Bacillus supports digestive balance and helps minimize gastrointestinal side effects during antibiotic therapy.
BL-CV 625 by Harksun offers a balanced and effective approach to infection management with added probiotic protection for better patient comfort and recovery.